It was in 1993 that Kharitonin started to build his company, which now has a market capitalization of more than $3 billion. At the time, he teamed up with billionaires Roman Abramovich and Evgeny Shvidler to purchase plants from US ICN Pharmaceuticals Russian and thus set the base for Pharmstandard. The trio spent $55 million for the acquisition of the plants. Throughout the 2007 IPO in London, investors estimated the company at $2.2 billion. Arbidol is only one of the well-known drugs that the company is still producing today. Meanwhile, Viktor Kharitonin is building a network of private clinics in Russia.
